SCHEMBL16416048

SCHEMBL16416048

CCc1nc(C)n(CC=O)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15157117 0.78 L3MBTL1 (0.34) —
SCHEMBL18673167 0.66 — —
SCHEMBL29954122 0.65 ALDH1A1 (0.33) —
SCHEMBL9344016 0.64 — —
SCHEMBL19655633 0.63 LMNA (0.30) —
SCHEMBL12251582 0.61 — —
SCHEMBL29955334 0.61 ALDH1A1 (0.52) —
SCHEMBL13219776 0.61 — —
SCHEMBL4469295 0.60 APAF1 (0.32) —
SCHEMBL29796735 0.60 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3024832-A1 1-(PIPERAZIN-1-YL)-2-([1,2,4]TRIAZOL-1-YL)-ETHANONE DERIVATIVES Actelion Pharmaceuticals Ltd. (CH) 2016-06-01 — — EP disclosed
WO-2015011099-A1 1-(PIPERAZIN-1-YL)-2-([1,2,4]TRIAZOL-1-YL)-ETHANONE DERIVATIVES ACTELION PHARMACEUTICALS LTD (CH) 2015-01-29 — — WO disclosed
Send feedback